Grunenthal Logo

External Link

You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.

Title
Description
Trial IDKF5503/62
CompoundTapentadol
Trials sponsorGrünenthal GmbH
Trial phase2
Brief title
IndicationAcute Pain, Bunionectomy
UTN
CTG IDNCT01435577
CTIS ID (former EudraCT)
Trial statusCompleted
FPISeptember 26, 2011
LPOFebruary 14, 2012
CountriesGermany, United States
GenderAll
Age18 Years to 75 Years
ResultsYes
Pubmed
Documents